These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31598165)

  • 1. STING signaling is a potential immunotherapeutic target in colorectal cancer.
    Chon HJ; Kim H; Noh JH; Yang H; Lee WS; Kong SJ; Lee SJ; Lee YS; Kim WR; Kim JH; Kim G; Kim C
    J Cancer; 2019; 10(20):4932-4938. PubMed ID: 31598165
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer cell-intrinsic STING is associated with CD8 + T-cell infiltration and might serve as a potential immunotherapeutic target in hepatocellular carcinoma.
    Zhang Y; Zhai Q; Feng X; Chen D; Lu Y; Hu J; Xie H; Zhou L; Wu J; Zheng S
    Clin Transl Oncol; 2021 Jul; 23(7):1314-1324. PubMed ID: 33502741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Tumor Cell-Intrinsic Expression of Cyclic GMP-AMP Synthase (cGAS)-Stimulator of Interferon Genes (STING) on the Infiltration of CD8
    Nakajima S; Kaneta A; Okayama H; Saito K; Kikuchi T; Endo E; Matsumoto T; Fukai S; Sakuma M; Sato T; Mimura K; Saito M; Saze Z; Sakamoto W; Onozawa H; Momma T; Kono K
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage STING signaling promotes NK cell to suppress colorectal cancer liver metastasis via 4-1BBL/4-1BB co-stimulation.
    Sun Y; Hu H; Liu Z; Xu J; Gao Y; Zhan X; Zhou S; Zhong W; Wu D; Wang P; Rao Z; Kong L; Zhou H
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36927529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer.
    Lee SJ; Yang H; Kim WR; Lee YS; Lee WS; Kong SJ; Lee HJ; Kim JH; Cheon J; Kang B; Chon HJ; Kim C
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A STING-related prognostic score predicts high-risk patients of colorectal cancer and provides insights into immunotherapy.
    Chen SY; Chen S; Feng W; Li Z; Luo Y; Zhu X
    Ann Transl Med; 2021 Jan; 9(1):14. PubMed ID: 33553307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gasdermin E benefits CD8
    Luo B; Zhang S; Yu X; Tan D; Wang Y; Wang M
    Biomark Res; 2024 Jun; 12(1):59. PubMed ID: 38853246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of STING predicts poor prognosis in patients with gastric cancer.
    Song S; Peng P; Tang Z; Zhao J; Wu W; Li H; Shao M; Li L; Yang C; Duan F; Zhang M; Zhang J; Wu H; Li C; Wang X; Wang H; Ruan Y; Gu J
    Sci Rep; 2017 Feb; 7():39858. PubMed ID: 28176788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole Enhancing anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer.
    Liang B; Khan M; Storts H; Zhang EH; Zheng X; Xing X; Claybon H; Wilson J; Li C; Jin N; Fishel R; Miles WO; Wang JJ
    Mol Cancer Ther; 2024 Oct; ():. PubMed ID: 39382075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H5 blockade enhances CD8
    Wang J; Wu H; Chen Y; Zhu J; Sun L; Li J; Yao Z; Chen Y; Zhang X; Xia S; Chen W; Shi T
    Cell Death Discov; 2021 Sep; 7(1):248. PubMed ID: 34537815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorophore-Conjugated Anti-ICOS Antibody Enables Precise Prediction of Therapeutic Response of the STING Agonist in Colorectal Cancer
    Dong Y; Chen C; Suo B; Yue X; Han P; Zhou Y; Qiao H
    Mol Pharm; 2022 Nov; 19(11):3877-3883. PubMed ID: 36018674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy.
    Xu D; Lu X; Yang F; Jiang Z; Yang S; Bi L; Liu J; Shan H; Li D
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):641-655. PubMed ID: 37924341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
    Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
    Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy.
    Huang KC; Chiang SF; Chang HY; Hong WZ; Chen JY; Lee PC; Liang JA; Ke TW; Peng SL; Shiau AC; Chen TW; Yang PC; Chen WT; Chao KSC
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38749537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ILT4 in Colorectal Cancer Cells Induces Suppressive T Cell Contexture and Disease Progression.
    Yang Z; Gao A; Shi W; Wang J; Zhang X; Xu Z; Xu T; Zheng Y; Sun Y; Yang F
    Onco Targets Ther; 2021; 14():4239-4254. PubMed ID: 34321889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STING promotes proliferation and induces drug resistance in colorectal cancer by regulating the AMPK-mTOR pathway.
    Yao H; Wang S; Zhou X; Sun J; Zhou G; Zhou D; Chen G; Shi X; Chen J; Shi B; Tai Q; Mi X; Sun L; Yao Y; He S
    J Gastrointest Oncol; 2022 Oct; 13(5):2458-2471. PubMed ID: 36388670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral Cytotoxic T-Lymphocyte Density and PD-L1 Expression Are Prognostic Biomarkers for Patients with Colorectal Cancer.
    Calik I; Calik M; Turken G; Ozercan IH; Dagli AF; Artas G; Sarikaya B
    Medicina (Kaunas); 2019 Oct; 55(11):. PubMed ID: 31683723
    [No Abstract]   [Full Text] [Related]  

  • 18. A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ.
    Kikuchi T; Mimura K; Okayama H; Nakayama Y; Saito K; Yamada L; Endo E; Sakamoto W; Fujita S; Endo H; Saito M; Momma T; Saze Z; Ohki S; Kono K
    Oncol Lett; 2019 Dec; 18(6):5977-5985. PubMed ID: 31788072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies.
    Mullins SR; Vasilakos JP; Deschler K; Grigsby I; Gillis P; John J; Elder MJ; Swales J; Timosenko E; Cooper Z; Dovedi SJ; Leishman AJ; Luheshi N; Elvecrog J; Tilahun A; Goodwin R; Herbst R; Tomai MA; Wilkinson RW
    J Immunother Cancer; 2019 Sep; 7(1):244. PubMed ID: 31511088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of irinotecan silicasome nanoparticles with radiation therapy sensitizes immunotherapy by modulating the activation of the cGAS/STING pathway for colorectal cancer.
    Wang L; Zhang T; Zheng Y; Li Y; Tang X; Chen Q; Mao W; Li W; Liu X; Zhu J
    Mater Today Bio; 2023 Dec; 23():100809. PubMed ID: 37779919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.